-
Driven by distraction? Trump steps up stunts as US midterms loom
-
Number of missing in deadly Nepal, China floods jumps past 2,400
-
Springboks a wounded beast, warns All Blacks captain Savea
-
Birmingham City Seek First Championship Win Against Wrexham
-
Trump announces new US 'Space Academy'
-
Four-wicket Robinson stars as Pakistan collapse in second Test
-
Best Laser Printers in India: Top Options from HP, Brother and Canon
-
Alcaraz anxious after layoff but feels 'great' about wrist
-
US Monroe Doctrine Revival Risks Pushing Latin America Toward China
-
Bezzecchi edges Marquez brothers in blazing Spanish MotoGP practice
-
Former Spain captain Morata joins second-tier Leganes
-
Ukraine opposes reintegration of Russia to motorsport
-
Does the Nepal glacier collapse signal a new climate risk?
-
The chaotic saga of Kanye West's planned Russian concerts
-
Gianni Infantino’s FIFA Presidency Faces Unprecedented Governance Crisis
-
Missing soar over 2,400 after deadly Nepal, China floods
-
SmartMarket Solutions Announces Its BBB Accreditation with an A+ Rating
-
India Orders Wind Turbine Makers to Report on Data Localization for Cybersecurity
-
Greenland to open truth commission over forced contraception scheme
-
Leknessund breaks away to win emotional Vuelta stage seven
-
Stocks, dollar rise after Fed chief lifts rate expectations
-
Four-wicket Robinson stars as Pakistan all out for 110 in second Test
-
'Game-changer': solar ambulance completes test run in Kenya
-
Fed chair Warsh signals 'work to do' on high US inflation
-
Fernandez's Chelsea future uncertain as Alonso seeks commitment
-
Watkins's legacy at Villa untarnished, says Emery as Jackson arrives
-
Four plead guilty to London arson attack on Jewish ambulances
-
Spurs boss De Zerbi targets one more big signing before window shuts
-
Meta's teen safety deal runs into an unsolved problem: proving age
-
Fed chair Warsh flags high US inflation as 'concerning'
-
Windmills of change: Dutch raise mill in rare operation
-
Same Election Question, Two Different Odds: Predictions.io Launches Free Cross-Venue Comparison Tools
-
Netanyahu party in uproar as far-right refuses pleas to unite
-
Man Utd new signing Baleba sidelined for three weeks
-
Stocks advance with all eyes on Fed chair's speech
-
Juve's Yildiz to miss 'several months' with foot injury
-
War criminal Ratko Mladic's death lays bare Bosnia's wounds
-
Celine Dion arrives in France ahead of sold-out comeback dates
-
Thieves buy tickets before plundering necklace from Vienna museum
-
All-round Tongue stars for England in second Test against Pakistan
-
Swiss nuclear plant fully back online after heatwaves
-
UEFA's legal move 'massive escalation' in bitter Infantino feud
-
Bournemouth, Sunderland to face AC Milan in Europa League
-
MEXC Launches Earn Plus With Limited-Time Event Offering Up to 800% APR Booster
-
Once a legend, humpback whales make comeback in Brazil
-
Norway's new King Haakon VIII, popular face of shaken monarchy
-
'Ran for our lives': Tales of survival from Nepal-China disaster
-
Stocks rise ahead of Fed chair's policy speech
-
Bombay High Court Questions Police Probe in Disha Salian Death Case
-
Norway's new King Haakon VII, popular face of shaken monarchy
Johnson & Johnson faces UK lawsuit over talc cancer claim
Thousands of UK claimants have filed legal action against US pharmaceutical and cosmetics giant Johnson & Johnson alleging people diagnosed with cancers were exposed to asbestos in its talcum powder, lawyers said Thursday.
The company has faced a series of similar lawsuits in North America, with the latest UK claim filed in the High Court in London.
The law firm representing around 3,000 complainants in Britain said the compensation claim "is estimated to be more than £1 billion" ($1.3 billion).
They allege that either they or a family member developed forms of ovarian cancer or mesothelioma from using J&J's Baby Powder.
"The claim, which covers the period from 1965 to 2023, details how Johnson & Johnson knew that their talc products contained carcinogenic fibres, including asbestos, for more than 50 years," KP Law said.
The company "chose to keep it on the market in the pursuit of profit," it added, claiming J&J only withdrew their mineral talc from Britain in 2023, three years after it was taken off North American shelves.
A Johnson & Johnson spokesperson referred enquiries to its former consumer health arm Kenvue, which it separated from in August 2023.
"As a part of that separation, Kenvue retained the responsibility and any purported liability for talc related litigation outside of the United States and Canada," the spokesperson said.
A Kenvue spokesperson said the safety of J&J's Baby Powder "is backed by years of testing by independent and leading laboratories, universities, and health authorities in the UK and around the world".
The spokesperson added "the high-quality cosmetic grade talc" used in the powder "was compliant with any required regulatory standards, did not contain asbestos, and does not cause cancer".
US courts in April rejected a J&J offer to pay approximately $8 billion over 25 years to settle around 90,000 civil complaints there related to ovarian issues, without admitting liability.
The World Health Organization's cancer agency classified talc as "probably carcinogenic" for humans in July last year.
A summary of studies published in 2020 covering 250,000 women in the United States did not find a statistical link between the use of talc on the genitals and the risk of ovarian cancer.
A.Williams--AT